extreme 88 online casino

Washington, Nov 22 (AP) President-elect Donald Trump's allies on Capitol Hill rallied around Pete Hegseth, Trump's Pentagon pick, on Thursday even as new details surfaced about allegations that he had sexually assaulted a woman in 2017. The GOP embrace of Hegseth came as another controversial Trump nominee, Matt Gaetz, withdrew from consideration for attorney general. Gaetz said it was clear he had become a “distraction" amid pressure on the House to release an ethics report about allegations of his own sexual misconduct. An attorney for two women has said that his clients told House Ethics Committee investigators that Gaetz paid them for sex on multiple occasions beginning in 2017, when Gaetz was a Florida congressman. Fresh questions over the two nominees' pasts, and their treatment of women, arose with Republicans under pressure from Trump and his allies to quickly confirm his Cabinet. At the same time, his transition has so far balked at the vetting and background checks that have traditionally been required. While few Republican senators have publicly criticised any of Trump's nominees, it became clear after Gaetz's withdrawal that many had been harbouring private concerns about him. Oklahoma Sen. Markwayne Mullin, who served with Gaetz in the House, said it was a “positive move.” Mississippi Sen. Roger Wicker said it was a “positive development.” Maine Sen. Susan Collins said Gaetz “put country first and I am pleased with his decision.” After meeting with Hegseth, though, Republicans rallied around him. “I think he's going to be in pretty good shape,” said Wicker, who is expected to chair the Senate Armed Services Committee in the next Congress. Republican senators' careful words, and their early reluctance to publicly question Trump's picks, illustrated not only their fear of retribution from the incoming president but also some of their hopes that the confirmation process can proceed normally, with proper vetting and background checks that could potentially disqualify problematic nominees earlier. Gaetz withdrew after meeting with senators on Wednesday. Sen. Thom Tillis said Gaetz was “in a pressure cooker” when he decided to withdraw, but suggested that it would have little bearing on Trump's other nominees. “Transactions — one at a time,” he said. As the Hegseth nomination proceeds, Republicans also appear to be betting that they won't face much backlash for publicly setting aside the allegations of sexual misconduct — especially after Trump won election after being found liable for sexual abuse last year. Hegseth held a round of private meetings alongside incoming Vice President JD Vance on Thursday in an attempt to shore up support and told reporters afterward: “The matter was fully investigated and I was completely cleared, and that's where I'm gonna leave it.” A 22-page police report report made public late Wednesday offered the first detailed account of the allegations against him. A woman told police that she was sexually assaulted in 2017 by Hegseth after he took her phone, blocked the door to a California hotel room and refused to let her leave. The report cited police interviews with the alleged victim, a nurse who treated her, a hotel staffer, another woman at the event and Hegseth. Hegseth's lawyer, Timothy Palatore, said the incident was “fully investigated and police found the allegations to be false.” Hegseth paid the woman in 2023 as part of a confidential settlement to head off the threat of what he described as a baseless lawsuit, Palatore has said. Wicker played down the allegations against Hegseth, a former Fox News host, saying that “since no charges were brought from the authorities, we only have press reports.” Sen. Bill Hagerty, R-Tenn., said after his meeting with Hegseth that he "shared with him the fact that I was saddened by the attacks that are coming his way.” Hagerty dismissed the allegations as “a he-said, she-said thing” and called it a “shame” that they were being raised at all. The senator said attention should instead be focused on the Defence Department that Hegseth would head. It's one of the most complex parts of the federal government with more than 3 million employees, including military service members and civilians. Sexual assault has been a persistent problem in the military, though Pentagon officials have been cautiously optimistic they are seeing a decline in reported sexual assaults among active-duty service members and the military academies. Wyoming Sen. John Barrasso, who will be the No. 2 Republican in the Senate next year, said after his meeting with Hegseth that the nominee is a strong candidate who “pledged that the Pentagon will focus on strength and hard power – not the current administration's woke political agenda.” Senate Republicans are under pressure to hold hearings once they take office in January and confirm nominees as soon as Trump is inaugurated, despite questions about whether Trump's choices will be properly screened or if some, like Hegseth, have enough experience for the job. Senate Armed Services Chairman Jack Reed, who will be the top Democrat on the panel next year, said the reports on Hegseth “emphasised the need for a thorough investigation by the FBI on the background of all the nominees.” It takes a simple majority to approve Cabinet nominations, meaning that if Democrats all opposed a nominee, four Republican senators would also have to defect for any Trump choice to be defeated. Trump has made clear he's willing to put maximum pressure on Senate Republicans to give him the nominees he wants – even suggesting at one point that they allow him to just appoint his nominees with no Senate votes. But senators insist, for now, that they are not giving up their constitutional power to have a say. “The president has the right to make the nominations that he sees fit, but the Senate also has a responsibility for advice and consent,” said Republican Sen. Mike Rounds of South Dakota. In the case of Gaetz, he said, “I think there was advice offered rather than consent.” (AP) GRS GRS (This story has not been edited by THE WEEK and is auto-generated from PTI)What happens when 'The Simpsons' join 'Monday Night Football'? Find out during Bengals-Cowboys

ADBE Earnings: Adobe Sinks as Soft Guidance Overshadows Q4 Beat - TipRanksLivestream: President Biden hosts NBA champion Celtics at the White House

In a series of archived posts from a now-deleted Reddit account, Luigi Mangione, the 26-year-old suspect in the killing of UnitedHealthcare CEO Brian Thompson , wrote extensively about a chronic back condition that he said caused him immense pain. The New York Police Department is now looking into whether a denied insurance claim related to that injury played a role in the shooting, Chief of Detectives Joseph Kenny told Fox News on Tuesday . “He was posting an X ray on his social media showing numerous screws being inserted into his spine. Some of the writings that he had, he was discussing the difficulty of sustaining that injury,” Kenny said. ”So we’re looking into whether or not the insurance industry either denied a claim from him, or didn’t help him out to the fullest extent.” Health insurers refusing to pay for cancer care, a surgical procedure or other life-saving treatment is a common frustration for many people in the U.S., and a potentially devastating problem for some, experts say. Roughly 6 in 10 insured adults experience problems when they use their insurance, including insurers refusing to pay for care, according to a 2023 survey published by KFF , a nonprofit group that researches health policy issues. Refusals to pay for care are more common for people with employer-based health insurance or private insurance compared to people with public insurance, such as Medicare and Medicaid. About 1 in 5 insured adults who use emergency services had a denied claim. It’s impossible to know the full scope of the problem, Dr. Adam Gaffney, a critical care physician at the Cambridge Health Alliance in Massachusetts, said. In the U.S., he said, private insurers are generally not required to publicly disclose data on denied claims, although the Affordable Care Act, also known as Obamacare, has some transparency rules. Another KFF report published last year found nearly 17% of in-network claims were denied in 2021 among people with Obamacare coverage. People and their doctors are often left to navigate numerous insurance plans — each has their own requirements and their own list of what’s covered — to determine whether they’ll be able to get the care they need, Gaffney said. “There’s a huge lack of clarity for patients and for doctors about what’s covered, what medicine can be started and what care will be approved and what will be blocked,” Gaffney said. “And there’s also a huge amount of administration burden that falls on medical practices to show that care is needed to get approved.” ”You can see how that kind of creates a degree of anarchy,” he added. Almost 3 of 5 adults who experience a coverage denial said their care was delayed as a result, according to a report from the CommonWealth Fund . When patients get denied, Gaffney said, they may not think to appeal, leaving them with medical debt . People don’t appeal because they may not realize it’s an option that can make a difference, or that they have the right to do it, surveys show . It’s more common for people with lower incomes to not appeal: A study published in the Journal of Health Politics, Policy and Law in August found those who were less affluent were significantly less likely than their wealthier counterparts to appeal denials of coverage. Arthur Caplan, the head of the medical ethics division at NYU Langone Medical Center in New York City, said denied claims is an issue many in the public have been furious with for a long time. He noted that it’s not just adults who experience it; children, particularly those in need of expensive treatments such as gene therapy, are routinely turned down by insurance companies. “Our health care is not seen as a right. It’s something you earn,” Caplan said. “This is a boiling cauldron that the shooting exposed.”

Residents, local elected officials and housing advocates rallied on Friday to call on a private equity landlord of a Bushwick rental building to allow the city to investigate the property after several fires displaced tenants from their homes. Isabella Bastiani and Angel Kaba, residents of 441 Wilson Ave., said they were ordered to evacuate from their homes in March after several fires in their building. Despite many attempts to get their landlord, the Raisner Group, a private equity firm, to fix the building during and after the fires, the tenants say their requests fell on deaf ears. Now they suspect the company is renovating the apartments for new tenants that will pay higher rent, an example of tenant displacement and gentrification. Elected officials are pushing the city to do more. City Council Member Sandy Nurse is not only trying to help the tenants deal with the "maze of bureaucracy" to secure housing as they continue to be locked out of their homes, but she is also considering drafting legislation to ban private equity firms from owning small homes and rent stabilized buildings. Private equity firms don’t have a stake in their communities and are using New York’s housing stock “as long term investments to seek profit and they want to maximize their profit," Nurse told BK Reader. Evelyn Cruz, district director for U.S. House Representative Nydia Velázquez, said city agencies are failing to exercise their duties. "They have all the tools in the box and they are not using the tools to protect our tenants," she said. Officials from the offices of Council Member Jennifer Gutiérrez, State Senator Julia Salazar and Public Advocate Jumaane Williams said unpermitted renovation work should be halted, a comprehensive review of the work after the fires by the Department of Buildings and Housing and Preservation & Development was needed, and all displaced residents should be guaranteed to return to their homes. “We talk about expanding housing in New York City when they cannot even protect our existing tenants,” Cruz added. “We should have a right to know who are these landlords, who are these 'predator' equity investors because they are investors.” Bastiani said she was forced to leave the building eight months ago after repeated electric fires and gas leaks, which caused the heat and hot water to be shut off. “You don't realize what living without heat and hot water and power will do,” Bastiani said. “We were all losing weight. We were so anxious about everything.” Despite Bastiani and Kaba calling the building’s management company, Taube Management, numerous times, help never came. “They were pretending they were doing things,” Bastiani said. “Like sending us little blurbs about, ‘oh, we're getting somebody in to do this’ and then they wouldn't show up or it would be somebody that didn't actually have any licenses to do electrical work.” The Raisner Group, under the name BK Immobilier LLC, was cited six times this year by the Department of Buildings for conducting electrical or construction work without a permit. The violations have racked up over $54,000 in fines. City HPD has also recorded over 140 violations on the property since the company took ownership in 2018. Juan Mayancela, director of Community Organizing for Council Member Gutierrez, called on developers and landlords “to respect our tenants, you have to not neglect them, not harass them.” Not only does Bastiani want a “livable” apartment but for “these rich people, to be taken down.” “They're just taking advantage of people that don't have money,” she said. The Brooklyn Reader reached out to Remy Raisner Rufenrach, who heads the Raisner Group and Taube Management, multiple times but did not receive a comment or response. The Bushwick building is now padlocked and Kaba and Bastiani have been forced to seek shelter elsewhere. Kaba, who has a 7-year-old daughter and is a survivor of abuse, relocated to a homeless shelter. “I don’t wish [this] on my worst enemy” Kaba said, describing the conditions of the shelter. “You don't have privacy, you don't have a personal life, you cannot have your own furniture, you have a curfew, you have to sign in and out... I want to have my life back.”Shares of Wave Life Sciences Ltd. ( NASDAQ:WVE – Get Free Report ) were down 2.6% during mid-day trading on Thursday . The stock traded as low as $13.06 and last traded at $13.06. Approximately 19,408 shares traded hands during trading, a decline of 98% from the average daily volume of 1,110,443 shares. The stock had previously closed at $13.41. Analysts Set New Price Targets Several brokerages have recently commented on WVE. B. Riley upped their price target on Wave Life Sciences from $19.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. upped their target price on shares of Wave Life Sciences from $13.00 to $17.00 and gave the company an “overweight” rating in a research report on Thursday, October 17th. Wells Fargo & Company lifted their price target on shares of Wave Life Sciences from $11.00 to $22.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Mizuho upped their price objective on shares of Wave Life Sciences from $19.00 to $22.00 and gave the stock an “outperform” rating in a report on Thursday, November 21st. Finally, StockNews.com downgraded shares of Wave Life Sciences from a “hold” rating to a “sell” rating in a report on Wednesday, November 13th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $22.22. Read Our Latest Analysis on WVE Wave Life Sciences Stock Down 4.3 % Insiders Place Their Bets In other Wave Life Sciences news, CEO Paul Bolno sold 51,234 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was sold at an average price of $14.32, for a total value of $733,670.88. Following the sale, the chief executive officer now directly owns 217,351 shares in the company, valued at $3,112,466.32. This trade represents a 19.08 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink . Also, insider Chris Francis sold 208,836 shares of Wave Life Sciences stock in a transaction dated Wednesday, October 16th. The stock was sold at an average price of $13.67, for a total value of $2,854,788.12. The disclosure for this sale can be found here . Insiders have sold a total of 436,544 shares of company stock worth $6,271,569 in the last quarter. 29.10% of the stock is owned by company insiders. Institutional Investors Weigh In On Wave Life Sciences Several hedge funds and other institutional investors have recently made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. increased its stake in Wave Life Sciences by 23.4% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,512 shares of the company’s stock valued at $37,000 after purchasing an additional 856 shares during the last quarter. Profund Advisors LLC acquired a new position in shares of Wave Life Sciences in the 2nd quarter valued at $53,000. Principal Financial Group Inc. purchased a new position in shares of Wave Life Sciences in the 2nd quarter valued at $74,000. Mackenzie Financial Corp grew its position in shares of Wave Life Sciences by 13.6% in the 2nd quarter. Mackenzie Financial Corp now owns 15,887 shares of the company’s stock valued at $79,000 after buying an additional 1,905 shares during the last quarter. Finally, Point72 DIFC Ltd purchased a new stake in Wave Life Sciences in the third quarter valued at $98,000. Institutional investors and hedge funds own 89.73% of the company’s stock. Wave Life Sciences Company Profile ( Get Free Report ) Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. See Also Receive News & Ratings for Wave Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wave Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter .None

Bowls miss out in 4 CFP teams in latest postseason twist

TV’s Dr. Oz invested in businesses regulated by agency Trump wants him to lead

None《TAIPEI TIMES》 Examination Yuan waives police height requirements

None

Juan Soto gets free luxury suite and up to 4 premium tickets for home games in $765M Mets dealSpending squeeze ‘could cost more than 10,000 Civil Service jobs’